Abstract: The disclosure relates to recombinant vectors and methods for using the same. In certain embodiments, the recombinant vectors are immunogenic.
Type:
Grant
Filed:
April 29, 2010
Date of Patent:
June 6, 2017
Assignees:
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS, ACADEMISCH ZIKENHUIS LEIDEN, CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS, UNIVERSITE DE MONTREAL, ARIZONA BOARD OF REGENTS, SANOFI PASTEUR LIMITED
Inventors:
Giuseppe Pantaleo, Thierry Calandra, Alexandre Harari, Thierry Roger, Mariano Esteban, Bertram Jacobs, Karen Kibler, Cornelius Melief, Rafick-Pierre Sekaly, Elias Haddad, James Tartaglia